Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biomea Fusion Inc
(NQ:
BMEA
)
5.830
+0.050 (+0.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biomea Fusion Inc
< Previous
1
2
3
4
5
6
7
Next >
BMF-219 Induces Complete Responses in Target Acute Myeloid Leukemia (AML) Patient Population
July 24, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Are (More) Big Gains Ahead for This Small Cap Biotech Stock?
June 28, 2023
With Biomea Fusion's share price nearly halved recently, oversold conditions seem to be setting in. This could be an opportunity for small cap growth investors.
Via
MarketBeat
Topics
Initial Public Offering
Exposures
Securities Market
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Biomea Fusion, Inc. and Encourages Investors with Losses to Contact the Firm
June 27, 2023
From
The Schall Law Firm
Via
Business Wire
What 18 Analyst Ratings Have To Say About Biomea Fusion
June 26, 2023
Via
Benzinga
Analyst Ratings for Biomea Fusion
May 18, 2023
Via
Benzinga
Recap: Biomea Fusion Q1 Earnings
May 02, 2023
Via
Benzinga
Analyst Ratings for Biomea Fusion
April 19, 2023
Via
Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Biomea Fusion, Inc. and Encourages Investors with Losses to Contact the Firm
June 26, 2023
From
The Schall Law Firm
Via
Business Wire
Dow Surges Over 50 Points; Avalo Therapeutics Shares Plummet
June 26, 2023
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining more than 50 points on Monday. The Dow traded up 0.18% to 33,788.05 while the NASDAQ fell 0.61% to 13,410.63. The S&P 500,...
Via
Benzinga
Crude Oil Rises; Carnival Shares Drop After Q2 Results
June 26, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq dropping around 80 points on Monday. The Dow traded down 0.02% to 33,719.54 while the NASDAQ fell 0.53% to 13,420.67. The S&P 500, also...
Via
Benzinga
Biomea Fusion Stock Is Trading Higher Today - Here's Why
June 26, 2023
Biomea Fusion Inc (NASDAQ: BMEA) announced the presentation of new clinical data from the first two cohorts from the Phase 2 portion of its ongoing Phase 1/2 clinical study (COVALENT-111) of BMF-219...
Via
Benzinga
Why Biomea Fusion Stock Crushed It This Week
March 30, 2023
A promising data readout in type 2 diabetes lit a fire underneath the biotech's stock this week.
Via
The Motley Fool
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 26, 2023
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
June 26, 2023
It's time to start off the week right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
Via
InvestorPlace
Biomea Fusion Presents Positive Clinical Data from the Initial Cohorts of the Ongoing Phase II Study (COVALENT-111) of BMF-219 in Patients with Type 2 Diabetes Mellitus at the American Diabetes Association (ADA) 83rd Scientific Sessions; 100 mg Cohort 3
June 23, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion to Present Late Breaking Data from Ongoing Phase II Trial, COVALENT-111, Evaluating BMF-219 in Patients with Type 2 Diabetes at ADA 2023
June 20, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2023
May 12, 2023
Via
Benzinga
Biomea Fusion Reports First Quarter 2023 Financial Results and Corporate Highlights
May 02, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion Announces FDA Clearance of Investigational New Drug (IND) Application for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia
May 01, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion to Present Late Breaking Data from Ongoing Phase II Trial, COVALENT-111, Evaluating BMF-219 in Patients with Type 2 Diabetes, at the ADA 83rd Scientific Sessions 2023 in June
April 19, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion To Present Two Preclinical Posters at the 114th AACR Annual Meeting
April 13, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
April 13, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
These 5 High-Growth Small-Cap Stocks Surged More Than 100% In Q1: What's Next?
April 05, 2023
The S&P 500 index, which is tracked by the SPDR S&P 500 ETF Trust (ARCA: SPY), posted a gain of 6.2% in the first quarter of 2023, while technology stocks in the Nasdaq 100 index, which is tracked by...
Via
Benzinga
$12M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
April 04, 2023
Although US stocks closed mixed on Monday, there were a few notable insider trades.
Via
Benzinga
Biomea Fusion Announces Pricing of Upsized Public Offering of Common Stock
March 29, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Is Cathie Wood Giving Up on Xpeng (XPEV) Stock?
March 29, 2023
Investors in Xpeng (XPEV) are wondering if Cathie Wood is giving up on the stock after a recent selloff during a strong rally.
Via
InvestorPlace
What's Going On With Biomea Fusion Stock?
March 29, 2023
Biomea Fusion Inc (NASDAQ: BMEA) shares are trading higher. The company reported fourth-quarter results after the bell and announced an offering Wednesday morning. Several analysts are out with...
Via
Benzinga
Dear SBNY Stock Fans, Mark Your Calendars for April 5
March 29, 2023
Fans of Signature Bank (SBNY) stock will want to keep an eye on the financial company for a catalyst when April 5 rolls around.
Via
InvestorPlace
BMEA Stock: Biomea Fusion Pops on Public Offering News
March 29, 2023
Biomea Fusion (BMEA) stock is climbing higher on Wednesday after the company announced a public offering plan and continues a recent rally.
Via
InvestorPlace
Biomea Fusion Announces Proposed Public Offering of Common Stock
March 29, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.